Health ❯ Diseases ❯ Blood Disorders

Sickle Cell Disease

Patient Experiences Casgevy Gene Therapies Cure Options Treatment Gene Therapy Treatment Options Symptoms Genetic Mutation Severe Forms Prevalence Genetic Causes Patient Demographics Impact on Black People Research and Development Lyfgenia CRISPR Gene Editing FDA Approval Stem Cell Transplant Genetic Factors Drug Approvals Gene Editing Causes Clinical Trials Cost of Treatment FDA Approvals Access to Treatment Global Impact Challenges in Developing Countries Future Treatments Pain Management Pain Crises Genetics Treatment Development

Agios’ Sickle Cell Pill Lifts Hemoglobin but Misses Pain-Crisis Goal in Phase 3

The mixed efficacy leaves mitapivat’s expansion prospects uncertain during an FDA review in beta thalassemia that targets a Dec. 7 decision.